GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
32.79
-1.42 (-4.15%)
At close: Aug 1, 2025, 4:00 PM
32.61
-0.18 (-0.55%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Company Description

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.

The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.

In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

GRAIL, Inc.
GRAIL logo
CountryUnited States
Founded2016
IndustryDiagnostics & Research
SectorHealthcare
Employees1,000
CEORobert Ragusa

Contact Details

Address:
1525 O’Brien Drive
Menlo Park, California 94025
United States
Phone833 694 2553
Websitegrail.com

Stock Details

Ticker SymbolGRAL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001699031
CUSIP Number384747101
ISIN NumberUS3847471014
Employer ID86-3673636
SIC Code8071

Key Executives

NamePosition
Robert P. RagusaChief Executive Officer and Director
Dr. Joshua J. Ofman M.D., M.S.H.SPresident
Aaron FreidinChief Financial Officer
Paul CiccolellaSenior Vice President of Research, Development and Operations
Abram Barth J.D., M.P.H.General Counsel
Trish RowlandVice President of Corporate Communications
Alison HighlanderSenior Vice President of Human Resources and Head of People Team
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEngPresident of International Business and BioPharma
Dr. Satnam Alag Ph.D.Senior Vice President of Software Engineering and Chief Security Officer
Andrew John PartridgeChief Commercial Officer

Latest SEC Filings

DateTypeTitle
Jul 29, 2025SCHEDULE 13GFiling
Jul 17, 2025SCHEDULE 13GFiling
Jul 15, 2025144Filing
Jun 30, 2025144Filing
Jun 12, 2025144Filing
May 30, 20258-KCurrent Report
May 16, 20258-KCurrent Report
May 14, 2025S-8Securities to be offered to employees in employee benefit plans
May 14, 202510-QQuarterly Report
May 13, 20258-KCurrent Report